Jedd Wolchok, director of the Meyer Cancer Center at Weill Cornell Medicine (Credit: Weill Cornell Medicine)
December 13, 2023 07:00 AM ESTUpdated 01:18 PM
R&D

Ex­clu­sive: Park­er In­sti­tute ex­pands to Weill Cor­nell Med­i­cine as it grows im­munother­a­py work

Katherine Lewin

News Reporter

The Park­er In­sti­tute for Can­cer Im­munother­a­py has added Weill Cor­nell Med­i­cine to its net­work of cen­ters across the US, with a fo­cus on cell ther­a­py …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times